← Back to all briefings
Data Strategy 6 min read Published Updated Credibility 73/100

EU data strategy

EU governments have agreed their European Health Data Space stance, signaling boards to prepare governance for primary and secondary health data flows, invest in infrastructure setup, and tighten DSAR and consent safeguards ahead of final negotiations.

Reviewed for accuracy by Kodi C.

Data strategy pillar illustration for Zeph Tech briefings
Data strategy, stewardship, and privacy briefings

On 6 December 2023 the Council of the European Union adopted its general approach to the proposed European Health Data Space (EHDS) regulation, setting the stage for trilogue negotiations with the European Parliament and Commission in 2024. The EHDS aims to set up a harmonized framework for primary use of electronic health data (care delivery) and secondary use (research, innovation, policy-making).

The Council's position clarifies national responsibilities for health data access bodies, the European infrastructure for cross-border data exchange (MyHealth@EU and HealthData@EU), and the safeguards expected for patient rights. Boards of healthcare providers, insurers, digital health companies, and researchers must now prepare governance structures, setup roadmaps, and DSAR operations that align with the emerging obligations.

The Council text emphasizes phased setup. Member states must designate national digital health authorities, ensure interoperability of electronic health records (EHRs), and connect to EU infrastructures. Secondary use will require data access bodies to manage permits, enforce secure processing environments, and monitor compliance with the EHDS rules. The Council also proposes adjustments to consent opt-outs, data categories eligible for reuse, and the role of industry standardization. Teams should treat the general approach as the blueprint for future compliance requirements.

Governance preparations for healthcare boards

Boards should commission an EHDS readiness assessment that maps organizational roles across primary and secondary data use. For hospitals and providers, governance documentation must evaluate EHR maturity, participation in national digital health authorities, and readiness to support cross-border patient access. For research institutions and pharma companies, the focus should be on secondary data permits, data altruism participation, and compliance with secure processing facility obligations. Risk committees should integrate EHDS into enterprise risk management, noting dependencies on national setup laws, interoperability standards, and funding mechanisms.

Boards must also designate accountable executives. Chief medical information officers, chief data officers, or digital health leads should own EHDS compliance programs, reporting progress to the board quarterly. Governance charters should outline responsibilities for aligning EHDS obligations with GDPR, Medical Device Regulation, and clinical safety requirements. Teams operating in multiple member states should create coordination councils that track national variations in setup timelines and supervisory expectations.

The Council's general approach highlights patient rights, including opt-out options for secondary use and transparency obligations. Boards should ensure that patient advisory councils or ethics committees are consulted when shaping consent models, opt-out experiences, and communication plans. Documenting stakeholder engagement supports accountability and shows good faith if regulators scrutinise governance choices.

Implementation roadmap: infrastructure, interoperability, and security

Implementation efforts will span infrastructure investments and policy updates. Primary use obligations require providers to adopt EHDS-compliant EHR systems capable of structured data exchange using common formats and terminologies (such as HL7 FHIR, SNOMED CT, and LOINC). IT roadmaps should budget for upgrading legacy systems, integrating patient access portals, and connecting to the MyHealth@EU network for cross-border services. Teams must also implement role-based access controls and audit trails that support patient access logs.

For secondary use, data access bodies and data holders must establish secure processing environments. These environments should provide approved researchers with controlled access to pseudonymised datasets, prohibit data downloads, and enforce output checks to prevent re-identification. Implementation teams should consider privacy-enhancing technologies, differential privacy, and statistical disclosure controls to meet the Council's expectations. Contracts with data users must clearly state permitted purposes, security requirements, retention limits, and penalties for misuse.

Interoperability requires standardization of metadata and data quality processes. Teams should adopt data catalogs that describe dataset provenance, quality metrics, and consent status. Data stewards must tag datasets with sensitivity levels, opt-out indicators, and applicable legal restrictions. Integration with national registries and terminologies will be essential for cross-border exchange; this may involve participating in European standardization activities and aligning with CEN/ISO norms.

Security remains essential. Healthcare teams should benchmark controls against NIS2 and sector-specific frameworks, covering identity and access management, encryption, network segmentation, and incident response. Incident response plans must include notification pathways to national digital health authorities and data protection authorities if of EHDS-related breaches. Teams should also test resilience of secure processing environments, including disaster recovery and business continuity.

DSAR and patient engagement improvements

The EHDS reinforces patient rights to access their electronic health data, obtain digital copies, and control secondary use. DSAR systems must therefore provide near real-time access to EHR data, with interfaces that display provenance, access history, and sharing preferences. Teams should integrate DSAR workflows with national patient portals where possible, ensuring consistent experiences. Identity verification should use eIDAS-compliant methods or national health identifiers to maintain security.

Patients will be able to restrict secondary use via opt-outs, subject to member state rules. DSAR teams must record opt-out requests, communicate them to data access bodies, and ensure that datasets released for secondary use respect these preferences. When opt-outs cannot be honored—for example, due to public interest exemptions—responses must explain the legal basis and available recourse. Documentation of opt-out handling should be retained for audits.

Transparency obligations include informing patients about data categories processed, access logs, and permissions granted to professionals. Teams should provide dashboards summarizing recent access events, research projects using their data, and mechanisms to lodge complaints. DSAR teams should coordinate with data protection officers to respond to complex requests involving multiple data holders or cross-border processing. Training should equip staff to explain EHDS rights in accessible language and to guide patients through opt-out mechanisms.

Vendor and partner coordination

The EHDS will reshape vendor relationships. Procurement teams should update contracts with EHR vendors, cloud providers, and analytics partners to include EHDS compliance obligations, interoperability standards, and data localization requirements where applicable. Vendors must support secure processing environments, audit logging, and integration with national infrastructures. Teams should develop vendor assessment frameworks that evaluate EHDS readiness, including API support, security certifications, and incident management capabilities.

Collaborations with research institutions and industry consortia will require governance agreements covering data sharing, intellectual property, and compliance with data access permits. Teams should establish joint steering committees to oversee project compliance, review DSAR impacts, and coordinate communications with data access bodies. Memoranda of understanding should specify how opt-outs, withdrawal of consent, and incident response responsibilities are handled among partners.

Monitoring, training, and preparing for trilogues

Because the EHDS regulation is still under negotiation, teams must maintain agile monitoring. Legal teams should track trilogue developments, analyze amendments, and brief governance bodies on changes affecting obligations, timelines, or penalties. Scenario planning should consider potential divergences between the Council and Parliament positions, such as data categories covered, opt-out scope, and enforcement structures.

Training programs should cover clinical staff, data scientists, IT professionals, and executives. Modules should explain EHDS objectives, governance structures, DSAR obligations, secure processing requirements, and interoperability standards. Regular refreshers will be necessary as the legal text evolves. Teams should also participate in national pilot projects or sandbox initiatives to gain practical experience with EHDS infrastructures.

By early strengthening governance, investing in compliant infrastructure, and enhancing DSAR and patient engagement practices, healthcare teams can position themselves to use the European Health Data Space while safeguarding patient trust and meeting forthcoming regulatory expectations.

Continue in the Data Strategy pillar

Return to the hub for curated research and deep-dive guides.

Visit pillar hub

Latest guides

Coverage intelligence

Published
Coverage pillar
Data Strategy
Source credibility
73/100 — medium confidence
Topics
EU data strategy · Health data · Data spaces
Sources cited
3 sources (consilium.europa.eu, data.consilium.europa.eu, iso.org)
Reading time
6 min

References

  1. European Health Data Space: Council agrees its position — Council of the European Union
  2. General approach of the Council on the proposal for a European Health Data Space — Council of the European Union
  3. ISO 8000-2:2022 — Data Quality Management — International Organization for Standardization
  • EU data strategy
  • Health data
  • Data spaces
Back to curated briefings

Comments

Community

We publish only high-quality, respectful contributions. Every submission is reviewed for clarity, sourcing, and safety before it appears here.

    Share your perspective

    Submissions showing "Awaiting moderation" are in review. Spam, low-effort posts, or unverifiable claims will be rejected. We verify submissions with the email you provide, and we never publish or sell that address.

    Verification

    Complete the CAPTCHA to submit.